Loures, Portugal

Álvaro Lopes


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Álvaro Lopes from Loures, Portugal

Introduction

Álvaro Lopes is a distinguished inventor based in Loures, Portugal, known for his innovative contributions to the pharmaceutical industry. With a remarkable portfolio of two patents, Lopes is paving the way for advancements in drug formulation technologies, particularly through the utilization of cyclodextrins.

Latest Patents

His latest patents, both centering on alkylated cyclodextrin compositions, represent a significant advancement in this field. The inventions focus on low-chloride alkylated cyclodextrin compositions, highlighting processes for their preparation and use. These innovative compositions are designed to deliver alkylated cyclodextrins with reduced levels of drug-degrading agents and chloride, ultimately enhancing the stability and efficacy of pharmaceutical formulations.

Career Highlights

Álvaro Lopes is currently affiliated with Cydex Pharmaceuticals, Inc., a company renowned for its expertise in cyclodextrin-based technologies. His work at Cydex has been instrumental in developing cutting-edge solutions that improve drug delivery and therapeutic efficacy across various medical applications.

Collaborations

Throughout his career, Lopes has collaboratively worked with esteemed colleagues, including Vincent D Antle and Daniel Monteiro. These collaborations foster an environment of innovation and knowledge sharing, further enhancing the impact of their collective work in the pharmaceutical field.

Conclusion

In conclusion, Álvaro Lopes stands out as a notable inventor with valuable contributions to the pharmaceutical industry through his patents on alkylated cyclodextrin compositions. His work at Cydex Pharmaceuticals, Inc. and collaborations with fellow innovators underscore his commitment to advancing drug formulation technologies, setting a benchmark for future inventions in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…